Formulations for ocular treatment
作者： Sreenivasu Mudumba , Thierry Nivaggioli , Philippe J. M. Dor , David A. Weber
DOI:
关键词:
摘要: Diseases and conditions associated with tissues of the body, including in eye, can be effectively treated by administering therapeutic agents to those tissues. Described herein are self-emulsifying formulations methods for delivering such A formulation may delivered an aqueous medium a subject, but not limited vitreous. method may, instance, used administer rapamycin or related compounds treat prevent choroidal neovascularization age-related macular degeneration, dry AMD. also administered systernically, as orally, transplant rejection subject. comprise rapamycin, compounds, other agents.
google.co.za 参考文章(80)
James Staunton, Peter Francis Leadlay, Lake Ee Khaw, Polyketides and their synthesis and use ,(1998)
Gholam A. Peyman, Enhanced recovery following ocular surgery ,(2005)
Laurie R. Lawin, Aron B. Anderson, Biodegradable controlled release bioactive agent delivery device ,(2005)
Gilbert Serpin, Jean-Marc Aiache, Pharmaceutical dosage form for ocular administration and preparation process ,(1993)
Bahram Khoobehi, Gholam A. Peyman, Dachuan Yang, Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same ,(1994)
Mark Goulet, Matthew J. Wyvratt, Thomas R. Beattie, Fluoromacrolides having immunosuppressive activity ,(1992)
Charles Edward Owen, Christoph Walker, Howard George Fox, Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound ,(2003)
Gregory S. Hamilton, Joseph P. Steiner, Hansjorg Sauer, Douglas T. Ross, Pipecolic acid derivatives for vision and memory disorders ,(1999)